Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
Raphaël Itzykson(Université Paris-Sud), Claude Preudhomme(Centre Hospitalier Universitaire de Lille), Jean‐Baptiste Micol(Université Paris-Saclay), Norbert Ifrah(Institut National du Cancer), Guy Leverger(Sorbonne Université), Manja Meggendorfer(Université Paris-Sud), Arnaud Petit(Sorbonne Université), Torsten Haferlach(Martin Luther Christian University), Pascale Cornillet‐Lefèbvre(Centre Hospitalier Universitaire de Reims), Alice Marceau‐Renaut(Hôpital Claude Huriez), Hélène Lapillonne(Sorbonne Université), Annette Fasan(Munich Leukemia Laboratory (Germany)), Nicolas Boissel(Inserm), Nicolas Duployez(Inserm), Hervé Dombret(University of London Institute in Paris), Éric Jourdan(Centre Hospitalier Universitaire de Nîmes), Gauthier Decool(Inserm)
Cited by 62
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
|New England Journal of Medicine|2018|5.7k